Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients.

about

Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients.

Item

http://www.wikidata.org/entity/Q48180197

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Association between Fluorescen ...... s in Type 2 Diabetic Patients.

@en

Association between Fluorescen ...... s in Type 2 Diabetic Patients.

@nl

type

Item

label

Association between Fluorescen ...... s in Type 2 Diabetic Patients.

@en

Association between Fluorescen ...... s in Type 2 Diabetic Patients.

@nl

prefLabel

Association between Fluorescen ...... s in Type 2 Diabetic Patients.

@en

Association between Fluorescen ...... s in Type 2 Diabetic Patients.

@nl

P1476

Association between Fluorescen ...... ns in Type 2 Diabetic Patients

@en

P2093

Alexis Guerin-Dubourg

http://www.w3.org/2001/XMLSchema#string

Cynthia Planesse

http://www.w3.org/2001/XMLSchema#string

Maxime Cournot

http://www.w3.org/2001/XMLSchema#string

Xavier Debussche

http://www.w3.org/2001/XMLSchema#string

P2860

Tissue sulfhydryl groups

Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM

Reactive oxygen species have a causal role in multiple forms of insulin resistance

Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008

Carotid ultrasonography: A potent tool for better clinical practice in diagnosis of atherosclerosis in diabetic patients.

Detection of oxidized and glycated proteins in clinical samples using mass spectrometry--a user's perspective.

Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes.

Fluorescent advanced glycation end products and their soluble receptor: the birth of new plasmatic biomarkers for risk stratification of acute coronary syndrome.

Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease.

Role of advanced glycation end products in cardiovascular disease.

P304

7989180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/7989180

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Meilhac

E Bourdon

Philippe Rondeau

P577

2017-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29362717

http://www.w3.org/2001/XMLSchema#string

P932

5736945

http://www.w3.org/2001/XMLSchema#string